Searchable abstracts of presentations at key conferences in endocrinology

ea0012p1 | Bone | SFE2006

Primary hyperparathyroidism – a great masquerader

Muthukrishnan J , Verma A , Jagdish Kumar P , Patro K , Modi KD , Jha S , Jha R

Primary Hyperparathyroidism is known to present with protean manifestations leading to misdiagnosis in the initial stages of the disease. In the developing world, most of the cases are detected late when they manifest with severe symptomatic metabolic bone disease or renal stones. Distal Renal Tubular Acidosis is a rare complication of primary hyperparathyroidism and should be looked for, in cases presenting with nephrolithiasis. Nuclear scintigraphy accurately localizes the t...

ea0007p303 | Clinical case reports | BES2004

Short stature in thalassemia major: multiple aetiologies

Jha S , Bano G , Nussey S

Short stature in thalassemia major: multiple aetiologies.A 24 year old Asian male with beta-thalassemia major was referred with symptoms of tiredness, weight gain, muscle weakness and depression. He had been treated elsewhere with blood transfusions, desferrioxamine and had undergone a splenectomy. He was known to have underlying cardiac dysfunction and was diagnosed to have hypogonadotrophic hypogonadism at the age of 17 years and primary hypothyroidism...

ea0002p8 | Clinical case reports | SFE2001

THE IMPORTANCE OF THE MOTHER AS A BIOASSAY FOR DIAGNOSING AND TREATING FOETAL THYROTOXICOSIS

Wahid S , Jha R , Brown K , Weaver J

The foetus of a mother with previous or current Graves disease is at risk of developing thyrotoxicosis. The mother can act as a bioassay to diagnose foetal thyrotoxicosis. We describe the difficulties in managing foetal thyrotoxicosis in a mother who could not act as a bioassay because of previous Graves disease treated by total thyroidectomy.A 35year old woman fell pregnant 3 months after a total thyroidectomy for relapsed Graves disease and concomitant...